Cord blood contains a rich supply of blood-forming stem cells that can treat more than 75 serious diseases, from leukemia to sickle cell disease. These stem cells are biologically younger and more potent than those found in adult bone marrow, which makes cord blood a uniquely valuable resource that can only be collected in the minutes after birth. Whether you donate it to a public bank or store it privately, saving cord blood preserves a biological resource that would otherwise be discarded with the placenta.
What Makes Cord Blood Stem Cells Special
The stem cells in umbilical cord blood are more primitive than their counterparts in adult bone marrow or circulating blood. That primitiveness is an advantage. Cord blood stem cells proliferate faster, respond more readily to growth signals, and are less dependent on their surrounding environment to survive and multiply. The concentration of certain colony-forming cells in cord blood is up to 15 times higher than in bone marrow, meaning a relatively small collection can pack serious therapeutic punch.
One of the most significant differences is telomere length. Telomeres are the protective caps on the ends of chromosomes that shorten each time a cell divides. Cord blood cells have longer telomeres than adult stem cells, which means they can undergo more rounds of division and produce a larger number of daughter cells before wearing out. This gives them the ability to sustain blood cell production for a longer period after transplant.
Cord blood stem cells also carry a lower risk of graft-versus-host disease, a potentially life-threatening complication where transplanted cells attack the recipient’s body. Because these cells are immunologically immature, they’re more tolerant of tissue mismatches. A cord blood transplant doesn’t require as precise an immune match as a bone marrow transplant, which opens the door for more patients to find a usable donor unit.
Diseases Cord Blood Can Treat Today
Cord blood transplants are an established treatment for a wide range of blood cancers, including acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma. In these cases, cord blood stem cells replace a patient’s damaged or cancerous blood-forming system with a healthy one after chemotherapy or radiation destroys the original.
Beyond cancer, cord blood treats serious genetic and immune disorders. Sickle cell disease, severe combined immunodeficiency (sometimes called “bubble boy” disease), severe aplastic anemia, and Wiskott-Aldrich syndrome are all treatable with cord blood transplants. It’s also used for certain metabolic disorders like adrenoleukodystrophy, Hurler syndrome, and Krabbe disease, where the transplanted cells can produce enzymes the patient’s body cannot make on its own.
Research Into New Uses
Clinical trials are exploring whether cord blood stem cells can help with conditions that have nothing to do with the blood system. Early-phase trials have tested cord blood infusions for cerebral palsy, autism spectrum disorder, and type 1 diabetes. A study using cord blood-derived stem cells in 20 children with autism found the treatment was safe and showed improvements in symptoms, though larger trials are needed to confirm effectiveness.
These applications fall under regenerative medicine, the idea that stem cells could repair damaged tissue rather than simply replace a blood system. The research is still in early stages, but the breadth of active clinical trials suggests cord blood’s therapeutic value may grow substantially in the coming years.
Public Banking vs. Private Banking
There are two ways to save cord blood, and they serve very different purposes. Donating to a public bank is free. Your cord blood becomes available to any patient worldwide who needs a matching transplant, much like donating blood to a blood bank. Public banks have released roughly 30 times more cord blood units for actual therapy than private banks have, making them the primary source of cord blood transplants in practice.
Private banking means paying to store your baby’s cord blood exclusively for your family. The typical cost is $1,000 to $2,000 upfront, plus about $100 per year in ongoing storage fees. The appeal is having a guaranteed genetic match for your child and a potential match for siblings or parents. A sibling has about a 25% chance of being a perfect immune match, and roughly 50% will be at least a partial match. Only about 30% of patients who need a stem cell transplant have a fully matched sibling donor available, which is one reason families with a known genetic risk consider private banking.
The American College of Obstetricians and Gynecologists (ACOG) recommends public banking as the preferred approach and states that routine private banking is not supported by the available evidence. The exception: private banking may make sense when a family member already has a condition that could benefit from a cord blood transplant. For most families without a known medical need, the odds of ever using a privately banked unit are very low.
How Long Cord Blood Stays Viable
When properly frozen in liquid nitrogen, cord blood lasts far longer than most people assume. Research from the José Carreras Cord Blood Bank tested units that had been stored for up to 29 years and found cell viability remained around 89%. Volume-reduced units (a more processed format) maintained viability above 84% after 25 years. These numbers mean a unit banked at birth could realistically be usable decades later, well into adulthood.
How Cord Blood Is Collected
Collection happens immediately after birth, once the umbilical cord has been cut. A needle is inserted into the cord’s vein, and blood drains by gravity into a collection bag. The process takes about 10 minutes and poses no risk or pain to the mother or baby.
One important consideration is delayed cord clamping, which most hospitals now practice because it benefits the newborn. About 30% of a baby’s blood volume sits in the placenta at the moment of birth, and waiting even a few minutes allows up to 25 milliliters per kilogram of body weight to transfer back to the infant. This improves the baby’s iron stores and blood volume, but it does reduce the amount of blood left in the cord for collection. In some cases, delayed clamping leaves too little blood for a viable banking sample. If you plan to bank cord blood, discuss timing with your delivery team beforehand so they can balance both priorities.
Who Benefits Most From Saving Cord Blood
Families with a history of blood cancers, sickle cell disease, immune deficiencies, or metabolic disorders stand to gain the most from private banking, since having a matched unit readily available can save critical time when a child or sibling needs a transplant. ACOG specifically supports private banking in these situations.
For families without a known genetic risk, donating to a public bank offers a way to contribute to the broader transplant pool. This is especially valuable for families from diverse racial and ethnic backgrounds, where finding a matched unrelated donor through traditional registries is significantly harder. Public cord blood banks help close that gap, but only if enough families donate. Not all hospitals participate in public banking programs, so checking whether your delivery hospital has a partnership with a public bank is worth doing early in pregnancy.